Florian Sennlaub

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
1
2009
UNIVERSITE PIERRE ET MARIE CURIE - PARIS (UPMC)
1
2015
OPTIS FRANCE S.A.
1
2001
UNIVERSITÉ PIERRE ET MARIE CURIE - PARIS
1
2015
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
1
2015
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
1
1
3
2001
2004
2009
VALORISATION HSJ, LIMITED PARTNERSHIP
2
2
2
2008
2013
2015
EYEGATE PHARMA S.A.S.
1
1
2004
2007
OPTIS FRANCE - INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE
1
2004
VALORISATION-RECHERCHE, LIMITED PARTNERSHIP
2
2
2
2008
2013
2015
UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
1
1
2012
2016
UNIVERSITE PIERRE ET MARIE CURIE
1
2012
UNIVERSITE DE MONTREAL
1
2009

Inventor Addresses

AddressDuration
PARIS, FROct 03, 19 - Oct 03, 19
Paris, FRMar 06, 03 - Jun 08, 23

Technology Profile

Technology Matters
A01K: ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS 1
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 16
A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 2

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
2023/0172,9192023AN INSULIN SENSITIZER FOR USE IN THE PREVENTION AND/OR TREATMENT OF THE DAMAGES CAUSED BY RETINAL DETACHMENT0
111918072021Lebecetin, a C-type lectin, as neovascularization inhibitor0
111425482021Agents that activate CD47 and their use in the treatment of inflammation0
110726612021Agents that inhibit the binding of CFH to CD11 b/CD18 and uses thereof0
105192322019Agents for use in the treatment of retinal inflammation1

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.